Jason Schense
Founder and Chief Technology Officer
bissiness Operations
Kuros Biosciences
Switzerland
Biography
Dr. Schense is working as Chief Technology Officer (CTO) responsible for the ongoing operational activities. Prior to joining Kuros, Jason was employed as a project leader at Straumann Biologics where he spent a year developing novel synthetic matrices for enhanced osseous healing associated with dental implants. From 2000 to 2002, Dr. Schense was employed as a project scientist at Kuros Therapeutics, where he was responsible for synthetic and fibrin-based materials for both bone and wound repair. He received his PhD in 1999 from the California Institute of Technology, Pasadena/CA, USA, working with Prof. Jeffrey Hubbell for the development of modified fibrin matrices for nerve regeneration. From this combined work, Dr. Schense has earned 19 publications, 10 conference presentations and is named as a co-inventor on all the patents in the field of delivery of growth factors from fibrin and modification of fibrin that the Company has licensed for tissue regeneration from the ETHZ and Caltech. He earned his BSc in Chemical Engineering from the Massachusetts Institute of Technology, Cambridge/MA, USA. Dr. Schense is a US and Italian citizen.
Research Interest
Novel synthetic matrices for enhanced osseous healing associated with dental implants Synthetic and fibrin-based materials for both bone and wound repair
